← Leaderboards
Scott Edward Counts
Michigan State University
$9,145,000
Attributed
$9,643,974
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$9,643,974 · 11
By mechanism
P01$4,384,446 · 3
R21$2,813,420 · 7
R01$2,446,108 · 1
Top collaborators
- Hua Xiao2 shared
- Kefei Yu2 shared
- Yu-Chung Norman Cheng1 shared
Most similar at Michigan State University
Same institution · by research overlap
- William F. Jackson$4,809,071
- Nicholas M Kanaan$11,893,156
- Janice Marie Diaz-Otero$81,899
- Dawn Kuszynski$91,556
- Kefei Yu$5,287,124
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseNeuronsTissuesImpaired CognitionCognitiveNeuron LossInsightMediatingPre-ClinicalMolecularCellsNerve DegenerationPathologyMild Cognitive ImpairmentPathway InteractionsNeuropathologyNeurofibrillary TanglesLinkGenesIn VitroTau ProteinsBrainFunctional Disorder
Grant awards (28)
Project 1 (MSU)-Neurofibrillary tangle evolution in mild cognitive impairment$597,486
P01 · FY2024 · AG · contact PI
Project 1 (MSU)-Neurofibrillary tangle evolution in mild cognitive impairment$610,628
P01 · FY2023 · AG · contact PI
Central noradrenergic mechanisms of cerebrovascular pathology in Alzheimer's disease$458,260
R01 · FY2023 · AG · contact PI
Project 1 (MSU)-Neurofibrillary tangle evolution in mild cognitive impairment$610,328
P01 · FY2022 · AG · contact PI
Central noradrenergic mechanisms of cerebrovascular pathology in Alzheimer's disease$467,975
R01 · FY2022 · AG · contact PI
Project 1 (MSU)-Neurofibrillary tangle evolution in mild cognitive impairment$609,427
P01 · FY2021 · AG · contact PI
Central noradrenergic mechanisms of cerebrovascular pathology in Alzheimer's disease$519,343
R01 · FY2021 · AG · contact PI
Magnetic susceptibility and volume of microvascular lesions as proof-of concept biomarkers for mixed dementia$437,221
R21 · FY2021 · AG
Project 1 (MSU)-Neurofibrillary tangle evolution in mild cognitive impairment$646,609
P01 · FY2020 · AG · contact PI
Central noradrenergic mechanisms of cerebrovascular pathology in Alzheimer's disease$510,044
R01 · FY2020 · AG · contact PI
Central noradrenergic mechanisms of cerebrovascular pathology in Alzheimer's disease$490,486
R01 · FY2019 · AG · contact PI
A novel mouse model to study DNA ligase 3 function in vivo$229,592
R21 · FY2019 · AI
Neurofibrillary Tangle Evolution in Mild Cognitive Impairment$277,199
P01 · FY2018 · AG · contact PI
A novel mouse model to study DNA ligase 3 function in vivo$190,954
R21 · FY2018 · AI
Molecular profiling of familial and sporadic Alzheimer's disease$193,750
R21 · FY2017 · AG · contact PI
Neurofibrillary Tangle Evolution in Mild Cognitive Impairment$338,735
P01 · FY2016 · AG · contact PI
Molecular profiling of familial and sporadic Alzheimer's disease$232,500
R21 · FY2016 · AG · contact PI
Neurofibrillary Tangle Evolution in Mild Cognitive Impairment$268,395
P01 · FY2015 · AG · contact PI
Tangle propagation in preclinical AD$223,259
R21 · FY2015 · AG · contact PI
Neurofibrillary Tangle Evolution in Mild Cognitive Impairment$290,164
P01 · FY2014 · AG · contact PI
Tangle propagation in preclinical AD$205,167
R21 · FY2014 · AG · contact PI
Neurofibrillary Tangle Evolution in Mild Cognitive Impairment$135,475
P01 · FY2014 · AG · contact PI
Neuroprotective microRNA pathways$217,586
R21 · FY2013 · AG · contact PI
Neuroprotective microRNA pathways$191,250
R21 · FY2012 · AG · contact PI
Gender differences in cholinergic molecular pathology in Alzheimer's disease$191,250
R21 · FY2009 · AG · contact PI
Gender differences in cholinergic molecular pathology in Alzheimer's disease$159,375
R21 · FY2008 · AG · contact PI
Proteomics of mild cognitive impairment in the elderly$184,266
R21 · FY2006 · AG · contact PI
Proteomics of mild cognitive impairment in the elderly$157,250
R21 · FY2005 · AG